Gentian Diagnostics ASA (GENT.OL)

NOK 39.0

(0.0%)

Total Assets Summary of Gentian Diagnostics ASA

Gentian Diagnostics ASA's latest annual total assets in 2023 was 180.58 Million NOK , down -3.84% from previous year.
Gentian Diagnostics ASA's latest quarterly total assets in 2024 Q3 was 189.09 Million NOK , up 1.2% from previous quarter.
Gentian Diagnostics ASA reported annual total assets of 187.79 Million NOK in 2022, down -11.33% from previous year.
Gentian Diagnostics ASA reported annual total assets of 211.79 Million NOK in 2021, down -9.98% from previous year.
Gentian Diagnostics ASA reported quarterly total assets of 189.09 Million NOK for 2024 Q3, up 1.2% from previous quarter.
Gentian Diagnostics ASA reported quarterly total assets of 186.58 Million NOK for 2024 Q1, up 3.32% from previous quarter.

Annual Total Assets Chart of Gentian Diagnostics ASA (2023 - 2013)

Historical Annual Total Assets of Gentian Diagnostics ASA (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	180.58 Million NOK	-3.84%
2022	187.79 Million NOK	-11.33%
2021	211.79 Million NOK	-9.98%
2020	235.26 Million NOK	3.56%
2019	227.18 Million NOK	-11.94%
2018	257.97 Million NOK	25.7%
2017	205.22 Million NOK	66.91%
2016	122.96 Million NOK	23.01%
2015	99.95 Million NOK	418.67%
2014	19.27 Million NOK	36.01%
2013	14.16 Million NOK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	186.86 Million NOK	0.15%
2024 Q3	189.09 Million NOK	1.2%
2024 Q1	186.58 Million NOK	3.32%
2023 Q2	190.4 Million NOK	2.7%
2023 Q1	185.4 Million NOK	-1.27%
2023 Q4	180.58 Million NOK	-3.97%
2023 FY	180.58 Million NOK	-3.84%
2023 Q3	188.04 Million NOK	-1.24%
2022 Q3	190.54 Million NOK	-5.52%
2022 Q4	187.79 Million NOK	-1.44%
2022 Q2	201.67 Million NOK	-0.26%
2022 FY	187.79 Million NOK	-11.33%
2022 Q1	202.21 Million NOK	-4.52%
2021 Q2	233.64 Million NOK	3.0%
2021 FY	211.79 Million NOK	-9.98%
2021 Q1	226.84 Million NOK	-3.58%
2021 Q4	211.79 Million NOK	-2.99%
2021 Q3	218.3 Million NOK	-6.56%
2020 Q2	218.98 Million NOK	-0.33%
2020 FY	235.26 Million NOK	3.56%
2020 Q3	214.13 Million NOK	-2.22%
2020 Q4	235.26 Million NOK	9.87%
2020 Q1	219.71 Million NOK	-3.29%
2019 Q1	256.27 Million NOK	-0.66%
2019 Q3	228.45 Million NOK	-2.32%
2019 Q2	233.88 Million NOK	-8.74%
2019 FY	227.18 Million NOK	-11.94%
2019 Q4	227.18 Million NOK	-0.56%
2018 Q4	257.97 Million NOK	-3.69%
2018 Q2	267.43 Million NOK	32.46%
2018 Q1	201.89 Million NOK	-1.62%
2018 FY	257.97 Million NOK	25.7%
2018 Q3	267.85 Million NOK	0.16%
2017 FY	205.22 Million NOK	66.91%
2017 Q2	213.98 Million NOK	0.01%
2017 Q4	205.22 Million NOK	-1.55%
2017 Q3	208.46 Million NOK	-2.58%
2017 Q1	213.97 Million NOK	74.02%
2016 Q3	94.84 Million NOK	0.0%
2016 FY	122.96 Million NOK	23.01%
2016 Q4	122.96 Million NOK	29.64%
2015 Q4	99.95 Million NOK	0.0%
2015 FY	99.95 Million NOK	418.67%
2014 FY	19.27 Million NOK	36.01%
2013 FY	14.16 Million NOK	0.0%

Peer Total Assets Comparison of Gentian Diagnostics ASA

Name	Total Assets	Total Assets Difference
Lifecare AS	86.38 Million NOK	-109.037%
Medistim ASA	505.71 Million NOK	64.291%